Arkolith/Insider Trading/CGEM/Form 4

Michaelson Jennifer

Chief Scientific OfficerCullinan Therapeutics, Inc. (CGEM) · full profile →Form 4 · filed Mar 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$125K
Net Open-Market Flow
-$125K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2026Option exercise(M)4K$4.30$17K179K
Mar 5, 2026Sell(S)8K$15.68$125K171K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 5, 2026Option exercise(M)4K—$0121K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-098781) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML